Clinical Trials Directory

Trials / Completed

CompletedNCT02064530

Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block

Postoperative Analgesic Effects of Dexmedetomidine Added to Bupivacaine for Transversus Abdominis Plane Block for Lower Abdominal Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
TC Erciyes University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

the aim of this study is evaluate postoperative analgesic effects of dexmedetomidine added to bupivacaine on TAP block in patients undergoing lower abdominal surgery.

Detailed description

TAP block is being used a method of multimodal balanced analgesia reduces postoperative pain, opioid requirement after surgery and adverse effect of opioid such as sedation, nausea vomiting and ileus. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine21 ml 0.5 %bupivacaine is applied interfasially
DRUGDexmedetomidine1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied interfasially
DRUGserum physiologic21 ml serum physiologic is applied interfasially

Timeline

Start date
2014-02-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-02-17
Last updated
2015-09-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02064530. Inclusion in this directory is not an endorsement.